Albert Heck

Dr. Albert Heck


Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2013 in Nature Methods
Verified
Journal Article
Open access
PDF file
DMDattatreya Mellacheruvu
Dattatreya Mellacheruvu
ZWZachary Wright
Zachary Wright
ACAmber L Couzens
Amber L Couzens
JLJean-Philippe Lambert
Jean-Philippe Lambert
NSNicole A St-Denis
Nicole A St-Denis
ANAlexey I Nesvizhskii
Alexey I Nesvizhskii
The Contaminant Repository for Affinity Purification (CRAPome) is a database of annotated negative control-data that can be used for filtering out nonspecific interactions in affinity purification-mass spectrometry experiments. Affinity purification coupled with mass spectrometry (AP-MS) is a widely used approach for the identification of protein-protein interactions. However, for any given protein of interest, determining which of the identified polypeptides represent bona fide interactors versus those that are background contaminants (for example, proteins that interact with the solid-phase support, affinity reagent or epitope tag) is a challenging task. The standard approach is to identify nonspecific interactions using one or more negative-control purifications, but many small-scale AP-MS studies do not capture a complete, accurate background protein set when available controls are limited. Fortunately, negative controls are largely bait independent. Hence, aggregating negative controls from multiple AP-MS studies can increase coverage and improve the characterization of background associated with a given experimental protocol. Here we present the contaminant repository for affinity purification (the CRAPome) and describe its use for scoring protein-protein interactions. The repository (currently available for Homo sapiens and Saccharomyces cerevisiae) and computational tools are freely accessible at http://www.crapome.org/ .

19 March 2009 in Nature Protocols
Verified
Journal Article
Closed access
PBPaul J Boersema
Paul J Boersema
RRReinout Raijmakers
Reinout Raijmakers
SLSimone Lemeer
Simone Lemeer
SMShabaz Mohammed
Shabaz Mohammed
AHAlbert Heck
Albert Heck

4 July 2011 in Nature
Verified
Journal Article
Closed access
PDF file
WLWim de Lau
Wim de Lau
NBNick Barker
Nick Barker
TLTeck Yew Low
Teck Yew Low
BKBon-Kyoung Koo
Bon-Kyoung Koo
VLVivian S. W. Li
Vivian S. W. Li
HCHans Clevers
Hans Clevers

15 August 2012 in Nature
Verified
Journal Article
Closed access
PDF file
BKBon-Kyoung Koo
Bon-Kyoung Koo
MSMaureen Spit
Maureen Spit
IJIngrid Jordens
Ingrid Jordens
TLTeck Yew Low
Teck Yew Low
DSDaniel E. Stange
Daniel E. Stange
HCHans Clevers
Hans Clevers

1 June 2012 in Cell
Verified
Journal Article
Closed access
VLVivian S.W. Li
Vivian S.W. Li
SNSer Sue Ng
Ser Sue Ng
PBPaul J. Boersema
Paul J. Boersema
TLTeck Yew Low
Teck Yew Low
WKWouter R. Karthaus
Wouter R. Karthaus
HCHans Clevers
Hans Clevers

14 March 2014 in Science
Verified
Journal Article
Closed access
PDF file
CDChristoph A. Diebolder
Christoph A. Diebolder
FBFrank J. Beurskens
Frank J. Beurskens
RJRob N. de Jong
Rob N. de Jong
RKRoman Koning
Roman Koning
KSKristin Strumane
Kristin Strumane
PPPaul W. H. I. Parren
Paul W. H. I. Parren
Hexing Complement: Complement activation is an immediate and potent immune defense mechanism, but how immunoglobulin G (IgG) antibodies activate complement at the molecular level is poorly understood. Using high-resolution crystallography, Diebolder et al. (p. 1260 ) show that human IgGs form hexameric structures by interacting with neighboring IgG molecules, and the complex then activates complement. Thus, IgG molecules and the complement system can coexist in the blood because complement activation will only be triggered after IgG senses a surface antigen and starts to aggregate.